1887

Abstract

strains expressing foreign antigens of various pathogens are capable of eliciting antigen-specific humoral and cellular immune responses. Attenuated strain 4550 (∆cya ) was used as an expression vector for herpes simplex virus (HSV) antigens. Genes encoding glycoprotein D (gD) and the immediate- early protein ICP27 of HSV-1 were cloned and expressed in plasmid pYA292 () and subsequently placed into 4550 . Following two oral immunizations, the protective efficacy of recombinant strains against zosteriform challenge with HSV-1 was measured in 3–4-week-old BALB/c mice. Levels of protection observed were 77% with the ICP27 construct but only 31 %with the gD construct. Zosteriform protection correlates with a CD4- mediated delayed-type hypersensitivity (DTH) reaction against HSV. Accordingly, significant DTH was observed only in mice immunized orally with the ICP27 construct. ELISA analysis of antigen-specific humoral responses failed to detect serum antibody responses following oral administration although recombinant were isolated from spleens of orally dosed mice up to day 30. Intravenous (i.v.) immunization with the gD- expressing construct did, however, induce detectable serum antibody responses. Some humoral IgA responses against gD in faecal samples were detected as early as 3 weeks post-oral immunization while those induced by the i.v. route were slightly lower. These data suggest that recombinant HSV antigens are capable of inducing immunity against HSV, some aspects of which are protective against HSV challenge.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-2-427
1997-02-01
2024-12-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/2/9018066.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-2-427&mimeType=html&fmt=ahah

References

  1. Aliabadi Z., Park Y. K., Slonczewski J. L., Foster J. W. 1988; Novel regulatory loci controlling oxygen and pH-regulated gene expression in Salmonella typhimurium. Journal of Bacteriology 70:842–851
    [Google Scholar]
  2. Banks T. A., Allen E. M., Dasgupta S., Sandri-Golden R., Rouse B. T. 1991; Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate early protein ICP27. Journal of Virology 65:3185–3191
    [Google Scholar]
  3. Banks T. A., Nair S., Rouse B. T. 1992; Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate early protein ICP27 of Herpes simplex virus. Journal of Virology 67:613–616
    [Google Scholar]
  4. Bowen J. C., Alpar O., Phillpotts R., Roberts I. S., Brown M. R. W. 1990; Preliminary studies on infection by attenuated Salmonella in guinea-pigs and on expression of herpes simplex virus. Research in Microbiology 141:873–877
    [Google Scholar]
  5. Brown A., Hormaeche C. E., Demarco de Hormaeche R., Winther M., Dougan G., Maskell D. J., Stocker B. A. D. 1987; An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. Journal ofInfectious Diseases 155:86–91
    [Google Scholar]
  6. Burke R. L. 1991; Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Reviews of Infectious Diseases 13: Suppl. 11 S906
    [Google Scholar]
  7. Burke R. L. 1992; Contemporary approaches to vaccination against HSV. In Current Topics in Microbiology and Immunology 179:137
    [Google Scholar]
  8. Cardenas L., Clements J. D. 1992; Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clinical Microbiology Reviews 5:328–342
    [Google Scholar]
  9. Chabalgoity J. A., Khan C. M. A., Nash A. A., Hormaeche C. E. 1996; A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8–23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Molecular Microbiology 19:791–801
    [Google Scholar]
  10. Challacombe S. J., Tomasi T. B.Jr 1980; Systemic tolerance and secretory immunity after oral immunization. Journal of Experimental Medicine 152:1459–1472
    [Google Scholar]
  11. Chatfield S. N., Dougan G., Roberts M. 1994; Progress in the development of multivalent oral vaccines based on live attenuated Salmonella. In Modern Vaccinology pp. 55–86 Kurstak E. Edited by New York: Plenum Medical;
    [Google Scholar]
  12. Chatfield S. N., Charles I. G., Makoff A. J., Oxer M. D., Dougan G., Pickard D., Slater D., Fairweather N. F. 1992; Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains : development of a single-dose oral tetanus vaccine. Bio/ Technology 10:888–892
    [Google Scholar]
  13. Cher D. J., Mosmann T. R. 1987; Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th-1 clones. Journal of Immunology 138:3688–3694
    [Google Scholar]
  14. Curtiss R.III Kelly S. M. 1987; Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infection and Immunity 55:3035–3043
    [Google Scholar]
  15. Davis R. W., Botstein D., Roth J. R. 1980 A Manual for Genetic Engineering. Advanced Bacterial Genetics Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  16. Denich K., Borlin P., O’Hanley P. D., Howard M., Heath A. W. 1993; Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infection and Immunity 61:4818–4827
    [Google Scholar]
  17. Doymaz M. Z., Foster C. M., DeStephano D., Rouse B. T. 1991; MHC-II restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clinical Immunology and Immunopathology398–409
    [Google Scholar]
  18. Fayolle C., O’Callaghan D., Martineau P., Charbit A., Clement J. M., Hofnung M., LeClerc C. 1994; Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium. Infection and Immunity 62:4310–4319
    [Google Scholar]
  19. Flynn J. L., Weiss W. R., Norris K. A., Seifert H. S., Kumar S., So M. 1990; Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivering system. Molecular Microbiology 4:2111–2118
    [Google Scholar]
  20. Fouts T. R., Tuskan R. G., Chada S., Hone D. M., Lewis G. K. 1996; Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine 13:1697–1705
    [Google Scholar]
  21. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., Kaufmann S. H. E. 1996; Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proceedings of the National Academy of Sciences, USA 93:1458–1463
    [Google Scholar]
  22. Holley E. A., Foster J. W. 1982; Bacteriophage P22 as a vector for Mu mutagenesis in Salmonella typhimuirium: isolation of nad-lac and pnc-lac gene fusions. Journal of Bacteriology 158:959–962
    [Google Scholar]
  23. Ianaro A., Xu D., O’Donnell C. A., Di Rosa M., Liew F. Y. 1995; Expression of TGF-β in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammatin, IL-2 and IFN-y, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 84:8–15
    [Google Scholar]
  24. Irie H., Harada Y., Kataoka M., Nagamuta M., Moriya Y., Saito M., Matsubara S., Kojima K., Sugawara Y. 1992; Efficacy of oral administration of live herpes simplex virus type-1 as a vaccine. Journal of Virology 66:2428–2434
    [Google Scholar]
  25. Karem K. L., Chatfield S., Kuklin N., Rouse B. T. 1995; Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infection and Immunity 63:4557–4563
    [Google Scholar]
  26. Karem K. L., Kanangat S., Rouse B. T. 1996; Cytokine expression in the gut associated lymphoid tissue (G. A. L. T.) after oral administration of attenuated Salmonella vaccine strains. Vaccine in press
    [Google Scholar]
  27. Manickan E., Yu Z., Rouse R. J. D., Wire W. S., Rouse B. T. 1995a; Induction of protective immunity against herpes simplex virus with DNA encoding the intermediate early protein ICP27. Viral Immunology 8:53–61
    [Google Scholar]
  28. Manickan E., Fancotte M., Kuklin N., Dewerchin M., Molitor C., Gheysen D., Slaoui M., Rouse B. T. 1995b; Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. Journal of Virology 69:4711–4716
    [Google Scholar]
  29. Martin S., Rouse B. T. 1987; The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D : clearance of local infection. Journal of Immunology 138:3431–3437
    [Google Scholar]
  30. Martin S., Zhu X., Silverstein S. J., Courtney R. J., Yao F., Jenkins F. J., Rouse B. T. 1990; Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. Journal of General Virology 71:2391–2399
    [Google Scholar]
  31. Mester J. C., Glorioso J. C., Rouse B. T. 1991; Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. Journal of Infectious Diseases 163:263–269
    [Google Scholar]
  32. Nahmias A. J., Josey W. E. 1968; Antig enic and biologic differences in herpesvirus. Progress in Medical Virology 10:110
    [Google Scholar]
  33. Nakayama K., Kelly S. M., Curtiss R.III 1988; Construction of an asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693–697
    [Google Scholar]
  34. Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. 1987; Different roles for L3T4+ and Lyt 2+ T-cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68:825–833
    [Google Scholar]
  35. Richman L. K. 1979; Immunological unresponsiveness after enteric administration of protein antigens. In Immunology of Breast Milk pp. 49–62 Ogra P. L., Dayton D. Edited by New York: Raven Press;
    [Google Scholar]
  36. Roberts M., Chatfield S. N., Dougan G. 1994; Salmonella as carriers of heterologous antigens. In Novel Delivery Systems for Oral Vaccines pp. 27–58 O’Hagan D. T. Edited by Boca Raton, Fla, CRC Press;
    [Google Scholar]
  37. Rouse B. T., Norley S., Martin S. 1988; Antiviral cytotoxic T lymphocyte induction and vaccination. Reviews of Infectious Diseases 10:16–33
    [Google Scholar]
  38. Simmons A., Nash A. A. 1984; Zosteriform spread of HSV as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. Journal of Virology 52:816–821
    [Google Scholar]
  39. Simmons A., Tscharke D. C. 1992; Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. Journal of Experimental Medicine 175:1337–1344
    [Google Scholar]
  40. Smith P. M., Wolcott R. M., Chervenak R., Jennings S. R. 1994; Control of acute cutaneous herpes simplex virus infection: T-cell mediated viral clearance is dependant upon interferon-gamma. Virology 202:76–88
    [Google Scholar]
  41. Weiner H. L. 1994; Oral tolerance. Proceedings of the National Academy of Sciences, USA 91:10762–10765
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-78-2-427
Loading
/content/journal/jgv/10.1099/0022-1317-78-2-427
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error